Sterling Pharmatech

Sterling Pharma Solutions is a leading global contract development and manufacturing organization (CDMO) specializing in complex small molecule API services. The company supports pharmaceutical and biotechnology clients throughout the entire product lifecycle, from discovery-stage development and clinical trials to large-scale commercial manufacturing. Sterling is particularly recognized for its expertise in challenging chemistries, including high-potency APIs (HPAPI), hazardous processes, and biocatalysis. Headquartered in the United Kingdom, the firm operates a network of state-of-the-art facilities across Europe and the United States. Following the acquisition of ADC Bio, the company has also expanded its capabilities into the antibody-drug conjugate (ADC) space, offering specialized linker and conjugation services.